Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP306857.RAlKNSeIjbLldhfRXZgA2d9dJwFndq4lnG4jAjmrGBwgU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP306857.RAlKNSeIjbLldhfRXZgA2d9dJwFndq4lnG4jAjmrGBwgU130_assertion type Assertion NP306857.RAlKNSeIjbLldhfRXZgA2d9dJwFndq4lnG4jAjmrGBwgU130_head.
- NP306857.RAlKNSeIjbLldhfRXZgA2d9dJwFndq4lnG4jAjmrGBwgU130_assertion wasGeneratedBy ECO_0000203 NP306857.RAlKNSeIjbLldhfRXZgA2d9dJwFndq4lnG4jAjmrGBwgU130_provenance.
- NP306857.RAlKNSeIjbLldhfRXZgA2d9dJwFndq4lnG4jAjmrGBwgU130_assertion wasDerivedFrom befree-20140225 NP306857.RAlKNSeIjbLldhfRXZgA2d9dJwFndq4lnG4jAjmrGBwgU130_provenance.
- NP306857.RAlKNSeIjbLldhfRXZgA2d9dJwFndq4lnG4jAjmrGBwgU130_assertion SIO_000772 22157961 NP306857.RAlKNSeIjbLldhfRXZgA2d9dJwFndq4lnG4jAjmrGBwgU130_provenance.
- NP306857.RAlKNSeIjbLldhfRXZgA2d9dJwFndq4lnG4jAjmrGBwgU130_assertion evidence source_evidence_literature NP306857.RAlKNSeIjbLldhfRXZgA2d9dJwFndq4lnG4jAjmrGBwgU130_provenance.
- NP306857.RAlKNSeIjbLldhfRXZgA2d9dJwFndq4lnG4jAjmrGBwgU130_assertion description "[Validation with the two independent datasets demonstrated that the malignancy-risk score had prognostic and predictive values: Of patients who did not receive ACT, those with a low malignancy-risk score had increased OS compared with a high malignancy-risk score (P = .007 and .01 for the GSE13212 and GSE14814 datasets, respectively), indicating a prognostic value; and in the GSE14814 dataset, patients receiving ACT survived longer in the high malignancy-risk score group (P = .03), and a statistically significant interaction between ACT and the signature was observed (P = .02).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP306857.RAlKNSeIjbLldhfRXZgA2d9dJwFndq4lnG4jAjmrGBwgU130_provenance.